Your browser doesn't support javascript.
loading
Humoral and cellular immune response induced by rVSVΔG-ZEBOV-GP vaccine among frontline workers during the 2013-2016 West Africa Ebola outbreak in Guinea.
Boum, Yap; Juan-Giner, Aitana; Hitchings, Matt; Soumah, Aboubacar; Strecker, Thomas; Sadjo, Mariama; Cuthbertson, Hannah; Hayes, Peter; Tchaton, Marie; Jemmy, Jean-Paul; Clarck, Carolyn; King, Deborah; Faga, Elisabetta Maria; Becker, Stephan; Halis, Bassam; Gunnstein, Norheim; Carroll, Miles; Røttingen, John-Arne; Kondé, Mandy Kader; Doumbia, Moise; Henao-Restrepo, Ana-Maria; Kieny, Marie-Paule; Cisse, Mohamed; Draguez, Bertrand; Grais, Rebecca F.
Afiliación
  • Boum Y; Epicentre, Yaoundé, Cameroon.
  • Juan-Giner A; Epicentre, Paris, France.
  • Hitchings M; Center for Communicable Disease Dynamics and Department of Epidemiology, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
  • Soumah A; Epicentre, Paris, France.
  • Strecker T; Institute of Virology, Philipps University, Marburg, Germany.
  • Sadjo M; Centre Hospital-Universitaire de Donka, Conakry, Guinea.
  • Cuthbertson H; Public Health England, National Infection Service, Porton Down, UK.
  • Hayes P; Division of Medicine, Department of Infectious Diseases, Imperial College London, UK.
  • Tchaton M; Epicentre, Paris, France.
  • Jemmy JP; Médecins Sans Frontières-Operational Center Belgium, Brussels, Belgium.
  • Clarck C; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
  • King D; Division of Medicine, Department of Infectious Diseases, Imperial College London, UK.
  • Faga EM; Médecins Sans Frontières-Operational Center Belgium, Brussels, Belgium.
  • Becker S; Institute of Virology, Philipps University, Marburg, Germany.
  • Halis B; Public Health England, National Infection Service, Porton Down, UK.
  • Gunnstein N; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway.
  • Carroll M; Public Health England, National Infection Service, Porton Down, UK.
  • Røttingen JA; Division of Infectious Disease Control, Norwegian Institute of Public Health, Oslo, Norway; Department of Health and Society, University of Oslo, Norway; Department of Global Health and Population, Harvard TH Chan School of Public Health, Boston, MA, USA; Coalition for Epidemic Preparedness Innovati
  • Kondé MK; Center of Excellence for Training, Research On Malaria & Priority Diseases In Guinea, Conakry, Guinea.
  • Doumbia M; World Health Organization, Geneva, Switzerland.
  • Henao-Restrepo AM; World Health Organization, Geneva, Switzerland.
  • Kieny MP; World Health Organization, Geneva, Switzerland.
  • Cisse M; Centre Hospital-Universitaire de Donka, Conakry, Guinea.
  • Draguez B; Médecins Sans Frontières-Operational Center Belgium, Brussels, Belgium.
  • Grais RF; Epicentre, Paris, France. Electronic address: Rebecca.grais@epicentre.msf.org.
Vaccine ; 38(31): 4877-4884, 2020 06 26.
Article en En | MEDLINE | ID: mdl-32499066
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Clinical_trials País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola / Ebolavirus Tipo de estudio: Clinical_trials País/Región como asunto: Africa Idioma: En Revista: Vaccine Año: 2020 Tipo del documento: Article